Skip to main content

Liposomes for Gene Transfer in Cancer Therapy

  • Protocol
  • First Online:
Immunotherapy of Cancer

Part of the book series: Methods in Molecular Biology ((MIMB,volume 651))

Abstract

We developed improved liposomes that produce efficacy for the treatment of cancer, cardiovascular diseases, and HIV-1-related diseases in small and large animal models. Because our processes are reproducible, we have standard operating procedures (SOPs) for the cGMP manufacture of these reagents that have been approved by the Food and Drug Administration for use in phase I/II clinical trials.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ramesh, R., Saeki, T., Templeton, N. S., Ji, L., Stephens, L. C., Ito, I., Wilson, D. R., Wu, Z., Branch, C. D., Minna, J. D., and Roth, J. A. (2001) Successful treatment of primary and disseminated human lung cancers by systemic delivery of tumor suppressor genes using an improved liposome vector. Mol Ther 3, 337–350.

    Article  PubMed  CAS  Google Scholar 

  2. Shi, H. Y., Liang, R., Templeton, N. S., and Zhang, M. (2002) Inhibition of breast tumor progression by systemic delivery of the maspin gene in a syngeneic tumor model. Mol Ther 5, 755–761.

    Article  PubMed  CAS  Google Scholar 

  3. Tirone, T. A., Fagan, S. P., Templeton, N. S., Wang, X. P., and Brunicardi, F. C. (2001) Insulinoma induced hypoglycemic death in mice is prevented with beta cell specific gene therapy. Ann Surg 233, 603–611.

    Article  PubMed  CAS  Google Scholar 

  4. Yotnda, P., Chen, D.-H., Chiu, W., Piedra, P. A., Davis, A., Templeton, N. S., and Brenner, M. K. (2002) Bilamellar cationic liposomes protect adenovectors from preexisting humoral immune responses. Mol Ther 5, 233–241.

    Article  PubMed  CAS  Google Scholar 

  5. Templeton, N. S., Lasic, D. D., Frederik, P. M., Strey, H. H., Roberts, D. D., and Pavlakis, G. N. (1997) Improved DNA: liposome complexes for increased systemic delivery and gene expression. Nature Biotech 15, 647–652.

    Article  CAS  Google Scholar 

  6. Lu, H., Zhang, Y., Roberts, D. D., Osborne, C. K., and Templeton, N. S. (2002) Enhanced gene expression in breast cancer cells in vitro and tumors in vivo. Mol Ther 6, 783–792.

    Article  PubMed  CAS  Google Scholar 

  7. Templeton, N. S. (2002) Liposomal delivery of nucleic acids in vivo. DNA Cell Biol 21, 857–867.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Templeton, N.S. (2010). Liposomes for Gene Transfer in Cancer Therapy. In: Yotnda, P. (eds) Immunotherapy of Cancer. Methods in Molecular Biology, vol 651. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-786-0_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-786-0_15

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60761-785-3

  • Online ISBN: 978-1-60761-786-0

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics